Hamilton Lane Advisors’s Q32 Bio QTTB Stock Holding History

Hamilton Lane Advisors’s Portfolio QTTB Stock Details QTTB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1,268	Closed	-$447K	–	60
2019 Q2	$447K	Buy	+1,268	New	+$498K	0.22%	35
2018 Q4	–	Sell	-5,634	Closed	-$2K	–	57
2018 Q3	$2K	Buy	+5,634	New	+$1.91M	0.81%	22

Other funds holding QTTB

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Temasek Holdings Singapore $30.5B AUM 13.98% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

RTW Investments New York $10B AUM 135.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Hamilton Lane Advisors's QTTB Position: Q3 2019 in Review

Hamilton Lane Advisors sold out of Q32 Bio (QTTB) in Q3 2019, closing a stake of 1,268 shares — an estimated $447K sold.

Hamilton Lane Advisors first reported a position in QTTB in Q3 2018 and held it in 2 quarters. The position peaked at $447K in Q2 2019. 80 funds tracked by Wall St. Rank hold QTTB as of Q3 2019.

Hamilton Lane Advisors reported no remaining Q32 Bio position as of Q3 2019 after selling out during the quarter.
Hamilton Lane Advisors sold 1,268 Q32 Bio shares in Q3 2019, an estimated $447K.
Hamilton Lane Advisors first reported a position in Q32 Bio in Q3 2018 and held it in 2 quarters.
Hamilton Lane Advisors's Q32 Bio position peaked at $447K in Q2 2019.
80 funds tracked by Wall St. Rank held Q32 Bio as of Q3 2019.

Based on Hamilton Lane Advisors's 13F filing for Q3 2019, filed 13 Nov 2019.